138 related articles for article (PubMed ID: 28486685)
1. Inhibition of Ser/Thr phosphatase PPM1D induces neutrophil differentiation in HL-60 cells.
Kamada R; Kudoh F; Yoshimura F; Tanino K; Sakaguchi K
J Biochem; 2017 Oct; 162(4):303-308. PubMed ID: 28486685
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein phosphatase PPM1D enhances retinoic acid-induced differentiation in human embryonic carcinoma cell line.
Ogasawara S; Chuman Y; Michiba T; Kamada R; Imagawa T; Sakaguchi K
J Biochem; 2019 Jun; 165(6):471-477. PubMed ID: 30576481
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation.
Ogasawara S; Kiyota Y; Chuman Y; Kowata A; Yoshimura F; Tanino K; Kamada R; Sakaguchi K
Bioorg Med Chem; 2015 Oct; 23(19):6246-9. PubMed ID: 26358280
[TBL] [Abstract][Full Text] [Related]
4. A small molecule inhibitor of p53-inducible protein phosphatase PPM1D.
Yagi H; Chuman Y; Kozakai Y; Imagawa T; Takahashi Y; Yoshimura F; Tanino K; Sakaguchi K
Bioorg Med Chem Lett; 2012 Jan; 22(1):729-32. PubMed ID: 22115592
[TBL] [Abstract][Full Text] [Related]
5. The role of PPM1D in cancer and advances in studies of its inhibitors.
Deng W; Li J; Dorrah K; Jimenez-Tapia D; Arriaga B; Hao Q; Cao W; Gao Z; Vadgama J; Wu Y
Biomed Pharmacother; 2020 May; 125():109956. PubMed ID: 32006900
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipid droplet formation by Ser/Thr protein phosphatase PPM1D inhibitor, SL-176.
Kamada R; Kimura N; Yoshimura F; Tanino K; Sakaguchi K
PLoS One; 2019; 14(2):e0212682. PubMed ID: 30811466
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of C-terminal truncated PPM1D enhances the effect of doxorubicin on cell viability in human colorectal carcinoma cell line.
Kozakai Y; Kamada R; Kiyota Y; Yoshimura F; Tanino K; Sakaguchi K
Bioorg Med Chem Lett; 2014 Dec; 24(24):5593-5596. PubMed ID: 25466181
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses.
Uyanik B; Goloudina AR; Akbarali A; Grigorash BB; Petukhov AV; Singhal S; Eruslanov E; Chaloyard J; Lagorgette L; Hadi T; Baidyuk EV; Sakai H; Tessarollo L; Ryffel B; Mazur SJ; Lirussi F; Garrido C; Appella E; Demidov ON
Nat Commun; 2021 Jun; 12(1):3622. PubMed ID: 34131120
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer.
Nahta R; Castellino RC
Biochem Pharmacol; 2021 Feb; 184():114362. PubMed ID: 33309518
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1).
Hayashi R; Tanoue K; Durell SR; Chatterjee DK; Jenkins LM; Appella DH; Appella E
Biochemistry; 2011 May; 50(21):4537-49. PubMed ID: 21528848
[TBL] [Abstract][Full Text] [Related]
13. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract][Full Text] [Related]
14. PPM1D activity promotes the replication stress caused by cyclin E1 overexpression.
Martinikova AS; Stoyanov M; Oravetzova A; Kok YP; Yu S; Dobrovolna J; Janscak P; van Vugt M; Macurek L
Mol Oncol; 2024 Jan; 18(1):6-20. PubMed ID: 37067201
[TBL] [Abstract][Full Text] [Related]
15. Dual roles for the phosphatase PPM1D in regulating progesterone receptor function.
Proia DA; Nannenga BW; Donehower LA; Weigel NL
J Biol Chem; 2006 Mar; 281(11):7089-101. PubMed ID: 16352595
[TBL] [Abstract][Full Text] [Related]
16.
Kahn JD; Miller PG; Silver AJ; Sellar RS; Bhatt S; Gibson C; McConkey M; Adams D; Mar B; Mertins P; Fereshetian S; Krug K; Zhu H; Letai A; Carr SA; Doench J; Jaiswal S; Ebert BL
Blood; 2018 Sep; 132(11):1095-1105. PubMed ID: 29954749
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma.
Kojima K; Maeda A; Yoshimura M; Nishida Y; Kimura S
Oncotarget; 2016 Oct; 7(43):69625-69637. PubMed ID: 27626308
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D.
Chuman Y; Yagi H; Fukuda T; Nomura T; Matsukizono M; Shimohigashi Y; Sakaguchi K
Protein Pept Lett; 2008; 15(9):938-48. PubMed ID: 18991770
[TBL] [Abstract][Full Text] [Related]
19. Identification of PPM1D as an essential Ulk1 phosphatase for genotoxic stress-induced autophagy.
Torii S; Yoshida T; Arakawa S; Honda S; Nakanishi A; Shimizu S
EMBO Rep; 2016 Nov; 17(11):1552-1564. PubMed ID: 27670885
[TBL] [Abstract][Full Text] [Related]
20. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
